IRIS
BARBANTI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 9.396
EU - Europa 8.108
NA - Nord America 4.439
SA - Sud America 729
AF - Africa 38
OC - Oceania 8
Totale 22.718
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 7.820
IE - Irlanda 5.955
US - Stati Uniti d'America 4.379
SG - Singapore 1.183
GB - Regno Unito 861
BR - Brasile 675
CH - Svizzera 405
FI - Finlandia 310
IT - Italia 170
DE - Germania 168
TR - Turchia 123
CN - Cina 89
EE - Estonia 40
FR - Francia 38
CA - Canada 36
CZ - Repubblica Ceca 35
NL - Olanda 32
KR - Corea 25
BD - Bangladesh 22
RU - Federazione Russa 22
IN - India 21
MX - Messico 21
AR - Argentina 19
PL - Polonia 17
EC - Ecuador 13
PK - Pakistan 13
UZ - Uzbekistan 13
AT - Austria 11
IQ - Iraq 11
IR - Iran 11
JP - Giappone 11
SE - Svezia 11
ZA - Sudafrica 9
EG - Egitto 8
MA - Marocco 8
TW - Taiwan 8
UA - Ucraina 8
AU - Australia 7
ES - Italia 6
IL - Israele 6
CO - Colombia 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
CL - Cile 4
ID - Indonesia 4
JO - Giordania 4
PH - Filippine 4
SA - Arabia Saudita 4
VE - Venezuela 4
BE - Belgio 3
ET - Etiopia 3
KE - Kenya 3
LT - Lituania 3
LV - Lettonia 3
PE - Perù 3
PY - Paraguay 3
UG - Uganda 3
UY - Uruguay 3
AM - Armenia 2
AZ - Azerbaigian 2
CY - Cipro 2
DK - Danimarca 2
TH - Thailandia 2
TN - Tunisia 2
VN - Vietnam 2
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
TG - Togo 1
Totale 22.718
Salva come PNG Salva come JPEG
Città #
Hong Kong 7.819
Dublin 5.918
London 821
Ashburn 815
Boardman 800
Santa Clara 424
Zurich 405
Singapore 371
Helsinki 307
The Dalles 274
Washington 197
Istanbul 110
Los Angeles 82
São Paulo 52
Munich 46
Assago 42
Chicago 37
San Francisco 26
Seattle 25
Seoul 25
Belo Horizonte 21
Brno 21
Frankfurt am Main 21
Milan 21
Rio de Janeiro 21
New York 18
Brooklyn 17
Amsterdam 15
Brasília 15
Montreal 14
Olomouc 14
Shanghai 14
Warsaw 14
Falkenstein 12
Boston 11
Catania 11
Salvador 11
Stockholm 11
Porto Alegre 10
Rome 10
Tashkent 10
Clifton 9
Düsseldorf 9
Piscataway 9
Mexico City 8
Tappahannock 8
Bexley 7
Chennai 7
Curitiba 7
Dallas 7
Duque de Caxias 7
Fortaleza 7
Genoa 7
Tanta 7
Atlanta 6
Johannesburg 6
Karachi 6
Manchester 6
Ottawa 6
Tokyo 6
Turin 6
Canoas 5
Cipolletti 5
Dhaka 5
Goiânia 5
Guangzhou 5
Joinville 5
Lauterbourg 5
Manaus 5
Phoenix 5
Quito 5
Amman 4
Buenos Aires 4
Casablanca 4
Contagem 4
Guayaquil 4
Macapá 4
Mascalucia 4
Moscow 4
North Bergen 4
Pelotas 4
Ribeirão Preto 4
San Jose 4
São José do Rio Preto 4
São José dos Campos 4
Taipei 4
Toronto 4
Volta Redonda 4
Addis Ababa 3
Arapiraca 3
Arapongas 3
Araraquara 3
Bauru 3
Berlin 3
Brussels 3
Campinas 3
Campo Belo 3
Carapicuíba 3
Caratinga 3
Cariacica 3
Totale 19.203
Salva come PNG Salva come JPEG
Nome #
European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease 1.151
Prosthesis choice for transcatheter aortic valve replacement: Improved outcomes with the adoption of a patient-specific transcatheter heart valve selection algorithm 949
Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis 940
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation 697
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry 627
Embolic protection device in a patient with large left ventricular thrombus undergoing transcatheter aortic valve replacement 541
Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: A case-matched comparison 478
Predicting neocommissural orientation during TAVI workup 471
Aortic angle distribution and predictors of horizontal aorta in patients undergoing transcatheter aortic valve replacement 412
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 362
Development and validation of the D-PACE scoring system to predict delayed high-grade conduction disturbances after transcatheter aortic valve implantation 352
Le nuove frontiere della cardiologia interventistica strutturale 340
1-Year Outcomes After Transfemoral Transcatheter or Surgical Aortic Valve Replacement: Results From the Italian OBSERVANT Study 142
Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: A comparative analysis from the Italian OBSERVANT study 127
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 104
Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face? 101
Transcatheter mitral valve implantation: CardiAQ 100
Transcatheter aortic valve replacement in obese patients: procedural vascular complications with the trans-femoral and trans-carotid access routes 99
Late Degeneration of Transcatheter Aortic Valves: Pathogenesis and Management 90
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 87
Transcatheter aortic valve-in-valve implantation to treat aortic para-valvular regurgitation after TAVI 85
Procedural outcomes of the 34 mm EvolutR Transcatheter valve in a real-world population insights from the HORSE multicenter collaborative registry 85
Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis 84
Evaluation of current practices in transcatheter aortic valve implantation: The WRITTEN (WoRldwIde TAVI ExperieNce) survey 84
Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation 83
Transcatheter Mitral Valve Implantation: CardiAQ-Edwards 82
Clinical outcomes of transcatheter aortic valve implantation in patients younger than 70 years rejected for surgery: the AMTRAC registry 82
Impact of chronic kidney disease on outcomes after percutaneous mitral valve repair with the MitraClip system: insights from the GRASP registry 79
Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration 79
Functional and metabolic frailty predicts mortality in patients undergoing TAVI: Insights from the OBSERVANT II study 76
30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study 74
A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement 71
Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry 69
Managing complications after transcatheter aortic valve implantation 68
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 68
A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation 67
Acute kidney injury after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis: results from a large multicentre Italian research project 67
3-year outcomes of self-expanding Corevalve prosthesis - The Italian Registry 67
CharActeristics, sizing anD outcomes of stenotic, tapered, rapHe-type bicuspid aOrtic valves treated with trans-catheter device implantation: Insights the AD HOC registry 66
Early detection of transcatheter heart valve dysfunction 65
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation 65
Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients With Chronic Kidney Disease Stages 3b to 5 64
Safety and efficacy of drug eluting stents in patients with spontaneous coronary artery dissection 64
Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to high-risk transcatheter aortic valve implantation 64
Cerebral embolization during transcatheter aortic valve implantation 63
Early and Mid-Term Outcomes of Transcatheter Aortic Valve Replacement Using the New Generation Self-Expanding Corevalve Evolut R Device 63
Early and late outcomes after transcatheter versus surgical aortic valve replacement in obese patients 63
Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison 62
Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis 62
The Helio transcatheter aortic dock for patients with aortic regurgitation 62
Management of severe stenosis controversies and promises 62
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 61
Early and mid-term outcome of patients with low-flow-low-gradient aortic stenosis treated with newer-generation transcatheter aortic valves 61
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2 61
Transcatheter mitral valve repair: a brief review 60
Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less 60
Bioprosthetic valves for transcatheter aortic valve replacement 60
Early Adverse Impact of Transfusion After Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the TRITAVI Registry 60
Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study) 60
Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement 59
Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation 59
Predictors and safety of next-day discharge in patients undergoing transfemoral transcatheter aortic valve implantation 59
Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve 59
Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry 59
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement 58
Sex Differences in Transfemoral Transcatheter Aortic Valve Replacement 58
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 58
Long-term outcomes of concomitant transcatheter aortic valve implantation and percutaneous coronary intervention 58
One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry) 58
Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation 58
Permanent Pacemaker Implantation Following Valve-in-Valve Transcatheter Aortic Valve Replacement: VIVID Registry 58
Balloon-Expandable versus Self-Expandable Valves in Transcatheter Aortic Valve Implantation: Complications and Outcomes from a Large International Patient Cohort 58
OBSERVANT II: OBservational Study of Effectiveness of transcatheter aortic valve implantation with new geneRation deVices for severe Aortic steNosis Treatment. Study protocol 58
Early Discharge After Transcatheter Aortic Valve Replacement: Mature Times 58
Transcatheter aortic valve replacement with new-generation devices: A systematic review and meta-analysis 57
Transcatheter aortic valve implantation compared with surgical aortic valve replacement in patients with anaemia 57
Outcomes of Patients Undergoing Balloon Aortic Valvuloplasty in the TAVI Era: A Multicenter Registry 57
One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry 57
Balloon Aortic Valvuloplasty in the Transcatheter Aortic Valve Replacement Era: A “Die-Hard” Procedure 57
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 56
Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation 56
Prespecified Risk Criteria Facilitate Adequate Discharge and Long-Term Outcomes After Transfemoral Transcatheter Aortic Valve Implantation 56
Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement 56
Early Recovery of Left Ventricular Systolic Function after Transcatheter Aortic Valve Implantation 56
Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death 55
Plug-Based Endovascular Closure of Large Bore Aortofemoral Graft Arteriotomy for Transcatheter Aortic Valve Replacement 55
Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International Registry 55
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry 55
The failing right heart: implications and evolution in high-risk patients undergoing transcatheter aortic valve implantation 55
One-Year Outcomes after Surgical versus Transcatheter Aortic Valve Replacement with Newer Generation Devices 55
Protesi Percutanee Aortiche: Le indicazioni si allargano 55
Transcatheter aortic valve replacement in bicuspid aortic valve disease 55
Real-World Multiple Comparison of Transcatheter Aortic Valves: Insights From the Multicenter OBSERVANT II Study 55
Unusual interatrial membrane in the left atrium: A newer obstacle for transseptal-based percutaneous mitral valve repair techniques? 55
Early discharge after transfemoral transcatheter aortic valve implantation 55
Feasibility and predictors of early discharge after percutaneous edge-to-edge mitral valve repair 54
Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis 54
[Transcatheter aortic valve implantation: are we ready? If so, for which patients? Is it sustainable? The interventional cardiologist's point of view] 54
New-onset atrial fibrillation and increased mortality after transcatheter aortic valve implantation: A causal or spurious association? 54
Clinical Outcomes and Prognosis Markers of Patients With Liver Disease Undergoing Transcatheter Aortic Valve Replacement: A Propensity Score-Matched Analysis 53
Totale 13.162
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.453
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231.386 0 0 0 0 0 0 0 0 0 269 817 300
2023/20247.574 278 707 401 540 1.311 1.170 1.228 492 439 431 249 328
2024/202514.180 1.491 249 544 152 610 681 7.367 307 978 692 766 343
Totale 23.140